跳至主要内容
临床试验/NCT06211088
NCT06211088已完成不适用

Famotidine Versus Placebo in Emergency Pediatric Surgery As a Risk to Postoperative Nausea and Vomiting ꞉ a Comparative Study by Gastric Ultrasound Measurement

Aswan University Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
to evaluate the difference of the gastric volume by quantitative measurements of gastric antrum by gastric ultrasound preoperatively and postoperatively by using 5mg famotidine versus placebo as a risk factor of postoperative nausea and vomiting

研究概览

简要总结

The aim of this study is to evaluate the difference of the gastric volume by quantitative measurements of gastric antrum preoperatively and postoperatively by using 5mg famotidine versus placebo as a risk factor of PONV.

详细描述

Gastric ultrasound examinations will be performed preoperatively and postoperatively on patients undergoing emergency surgery in pediatric. Gastric cross-sectional area (CSA) will be measured, in order to estimate the gastric volume. The data that will be obtained will be used to evaluate a difference of the gastric volume between the two groups preoperatively and postoperatively and the possible relationship between the gastric volume difference and postoperative adverse event (PONV).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
2 Years 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Pediatrics patients aging between 2-13 years .
  • pediatrics undergo urgent surgery (i.e., surgery that cannot be postponed for more than 48 h since clinical onset).
  • PatientPediatrics come in trauma

排除标准

  • PatientPediatrics severly shocked .
  • PatientPediatrics with diffusely distended abdomen as this will obstacle gastric ultrasound .
  • PatientPediatrics with history of hypersenstivity to famotidine .
  • PatientPediatrics with hepatic or renal impairments

研究组 & 干预措施

famotidine plus10ml normal saline

Active Comparator

Group A:(n. 25) will receive a 5 mg of famotidine that will be diluted to 10ml normal saline in 2 minutes preinduction.

干预措施: famotidine plus10ml normal saline (Drug)

10ml normal saline

Placebo Comparator

Group B: Controlled group (n. 25) will receive a10ml normal saline preinduction.

干预措施: 10ml normal saline (Other)

结局指标

主要结局

to evaluate the difference of the gastric volume by quantitative measurements of gastric antrum by gastric ultrasound preoperatively and postoperatively by using 5mg famotidine versus placebo as a risk factor of postoperative nausea and vomiting

时间窗: 12 months

to evaluate the difference of the gastric volume by quantitative measurements of gastric antrum by gastric ultrasound preoperatively and postoperatively by using 5mg famotidine versus placebo as a risk factor of postoperative nausea and vomiting

次要结局

未报告次要终点

研究者

发起方
Aswan University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zaher Zaki Zaher

Director

Aswan University Hospital

研究点 (1)

Loading locations...

相似试验